Anti-angiogenic methods and compositions

Patent Citations (94)

Non-Patent Literature (174)

• Reik et al. (2004) Molecular Therapy, vol. 9 (1 supplement), p. S238, abstract 628.Examiner
• Wang et al. (2003) Molecular Therapy, vol. 8(1), 72-79.Examiner
• Tan et al. (2003) PNAS, vol. 100(21), 11997-12002.Examiner
• Greisman et al. (1997) Science, vol. 275, 657-661.Examiner
• Deonarain et al. (1998) Exp. Opin. Ther. Patents, vol. 8 (1), 53-69.Examiner
• Boeckle et al. (2006) The AAPS Journal, vol. 8(4), E731-E742.Examiner
• Lu et al. (2006) The AAPS Journal, vol. 8(3), E466-E478.Examiner
• Abe, et al., “Overexpression of Pigment Epithelium-Derived Factor Decreases Angiogenesis and Inhibits the Growth of Human Malignant Melanoma Cells in Vivo,” Am J Pathol 164:1225-1232 (2004).Applicant
• Ahmad, et al., “Antibody-Mediated Specific Binding and Cytotoxicity of Liposome-Entrapped Doxorubicin to Lung Cancer Cells in Vitro,” Cancer Res 52(17):4817-4820 (1992).Applicant
• Altschul, et al., “Basic Local Alignment Search Tool,” J. Mol. Biol. 215:403-410 (1990).Applicant
• Alvarez et al. “A Phase I Study of Recombinant Adenovirus Vector-Mediated Intraperitoneal Delivery of Herpes Simplex Virus Thymidine Kinase (HSV-TK) Gene and Intravenous Ganciclovir for Previously Treated Ovarian and Extraovarian Cancer Patients,” Hum. Gene Ther. 8(5):597-613 (1997).Applicant
• Beaucage et al., “Deoxynucleoside Phosphoramidites—A New Class of Key Intermediates for Deoxypolynucleotides,” Tetrahedron Letters 22:1859-1862 (1981).Applicant
• Behr et al., “Gene Transfer With Synthetic Cationic Amphiphiles: Prospects for Gene Therapy,” Bioconjug. Chem. 5(5):382-389 (1994).Applicant
• Berg and Shi, “The Galvanization of Biology: A Growing Appreciation for the Roles of Zinc,” Science 271:1081-1085 (1996).Applicant
• Bird et al., “Methylation-Induced Repression—Belts, Braces, and Chromatin,” Cell 99(5):451-454 (1999).Applicant
• Bitko & Barik, “Persistent Activation of Rela by Respiratory Syncytial Virus Involves Protein Kinase C, Underphosphorylated Ikappabbeta, and Sequestration of Protein Phosphatase 2A by the Viral Phosphoprotein,” J. Virol. 72(7):5610-5618 (1998).Applicant
• Blaese et al., “Vectors in Cancer Therapy: How Will They Deliver?” Cancer Gene Therapy 2:291-297 (1995).Applicant
• Blaese et al., “T Lymphocyte-Directed Gene Therapy for ADA-SCID: Initial Trial Results After 4 Years,” Science 270(5235):475-480 (1995).Applicant
• Buchscachher et al., “Human Immunodeficiency Virus Vectors for Inducible Expression of Foreign Genes,” J Virol 66(5):2731-2739 (1992).Applicant
• Carbonetti et al., “Use of Purtussis Toxin Vaccine Molecule PT9K/129G to Deliver Peptide Epitopes for Simulation of a Cytotoxic T Lymphocyte Response,” Abstr. Annu. Meet. Am. Soc. Microbiol. 95:295 (1995).Applicant
• Chern et al., “The Regulator of MAT2 (ROM2) Protein Binds to Early Maturation Promoters and Represses PVALF-Activated Transcription,” Plant Cell 8(2):305-321 (1996).Applicant
• Cho et al., “Analysis of the C-Terminal Region of Arabidopsis thaliana Apetalai As a Transcription Activation Domain,” Plant Mol. Biol. 40(3):419-429 (1999).Applicant
• Choo et al., “Toward a Code for the Interactions of Zinc Fingers With DNA: Selection of Randomized Fingers Displayed on Phage,” PNAS 91:11163-11167 (1994).Applicant
• Choo et al., “Selection of DNA Binding Sites for Zinc Fingers Using Randomized DNAs Reveals Coded Interactions,” PNAS 91:11168-11172 (1994).Applicant
• Cirillo et al., “Binding of the Winged-Helix Transcription Factor HNF3 to a Linker Histone Site on the Nucleosome,” EMBO J. 17:244-254 (1998).Applicant
• Clarke-Curtiss & Curtiss, “Analysis of Recombinant DNA Using Escherichia coli Minicells,” Methods in Enzymology 101:347-362 (1983).Applicant
• Colley, et al., “Conversion of a Golgi Apparatus Sialyltransferase to a Secretory Protein by Replacement of the NH2-Terminal Signal Anchor With a Signal Peptide,” J. Biol. Chem. 264(30):17619-17622 (1989).Applicant
• Collingwood, et al., “Nuclear Receptors: Coactivators, Corepressors and Chromatin Remodeling in the Control of Transcription,” J. Mol. Endocrinol. 23(3):255-275 (1999).Applicant
• Conn, et al., “Amino Acid and cDNA Sequences of a Vascular Endothelial Cell Mitogen That is Homologous to Platelet-Derived Growth Factor,” PNAS USA 87:2628-2632 (1990).Applicant
• Cordingley, et al., “Steroid-Dependent Interaction of Transcription Factors With the Inducible Promoter of Mouse Mammary Tumor Virus in Vivo,” Cell 48:261-270 (1987).Applicant
• Crystal, “Transfer of Genes to Humans: Early Lessons and Obstacles to Success,” Science 270(5235):404-410 (1995).Applicant
• Damm, et al., “Protein Encoded by V-ERBA Functions As a Thyroid-Hormone Receptor Antagonist,” Nature 339:593-597 (1989).Applicant
• Dawson, et al., “Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis,” Science 285:245-248 (1999).Applicant
• Deamer & Bangham, “Large Volume Liposomes by an Ether Vaporization Method,” Biochim. Biophys. Acta 443(3):629-634 (1976).Applicant
• Derossi, et al., “The Third Helix of the Antennapedia Homeodomain Translocates Through Biological Membranes,” J. Biol. Chem. 269(14):10444-10450 (1994).Applicant
• Desjarlais, et al., “Length-Encoded Multiplex Binding Site Determination: Application to Zinc Finger Proteins,” PNAS 91:11099-11103 (1994).Applicant
• Desjarlais, et al., “Toward Rules Relating Zinc Finger Protein Sequences and DNA Binding Site Preferences,” PNAS 89:7345-7349 (1992).Applicant
• DesjarlaisM et al., “Use of a Zinc-Finger Consensus Sequences Framework and Specificity Rules to Design Specific DNA Binding, Proteins” PNAS 90:2256-2260 (1993).Applicant
• Donelly, et al., “Targeted Delivery of Peptide Epitopes to Class I Major Histocompatibility Molecules by a Modified Pseudomonas Exotoxin,” PNAS 90(8):3530-3534 (1993).Applicant
• Doyle & Hunt, “Reduced Nuclear Factor Kappab (P65) Expression in Rat Primary Sensory Neurons After Peripheral Nerve Injury,” Neuroreport 8(13):2937-2942 (1997).Applicant
• Dranoff, et al., “A Phase I Study of Vaccination With Autologous, Irradiated Melanoma Cells Engineered to Secrete Human Granulocyte-Macrophage Colony Stimulating Factor,” Hum Gene Ther. 8(1)111-112 (1997).Applicant
• Dunbar, et al., “Retrovirally Marked CD34-Enriched Peripheral Blood and Bone Marrow Cells Contribute to Long-Term Engraftment After Autologous Transplantation,” Blood 85(11):3048-3057 (1995).Applicant
• Eisenberg, et al., “Promoter Domains Required for Expression of Plasmid-Borne Copies of the Herpes Simplex Virus Thymidine Kinase Gene in Virus-Infected Mouse Fibroblasts and Microinjected Frog Oocytes,” Mol. Cell. Biol. 5:1940-1947 (1985).Applicant
• Ellem, et al., “A Case Report: Immune Responses and Clinical Course of the First Human Use of Granulocyte/Macrophage-Colony-Stimulating-Factor-Transduced Autologous Melanoma Cells for Immunotherapy,” Cancer Immunol Immunother. 44(1):10-20 (1997).Applicant
• Elliott & O'Hare, “Intercellular Trafficking and Protein Delivery by a Herpesvirus Structural Protein,” Cell 88(3):223-233 (1997).Applicant
• Evans, “The V-ERBA Oncogene Is a Thyroid Hormone Receptor Antagonist,” Int. J. Cancer Suppl. 4:26-28 (1989).Applicant
• Fahraeus, et al., “Inhibition of PRB Phosphorylation and Cell-Cycle Progression by a 20-Residue Peptide Derived From P16CDKN2/INK4A,” Current Biology 6:84 (1996).Applicant
• Fields, et al., “A Novel Genetic System to Detect Protein-Protein Interactions,” Nature 340:245-246 (1989).Applicant
• Fink, et al., “Identification of a Tightly Regulated Hypoxia-Response Element in the Promoter of Human Plasminogen Activator Inhibitor-1,” Blood 99:2077-2083 (2002).Applicant
• Fraley, et al., “Entrapment of a Bacterial Plasmid in Phospholipid Vesicles: Potential for Gene Transfer,” PNAS 76:3348-3352 (1979).Applicant
• Gao, et al., “Cationic Liposome-Mediated Gene Transfer,” Gene Therapy 2:710-722 (1995).Applicant
• Garcia, et al., “Inhibition of Xenografted Human Melanoma Growth and Prevention if Metastasis Development by Dual Antiangiogenic/Antitumor Activities of Pigment Epithelium-Derived Factor,” Cancer Res 64:5632-5642 (2004).Applicant
• Gibson, et al., “A Novel Method for Real Time Quantitative RT-PCR,” Genome Research 6:995-1001 (1996).Applicant
• Goff, et al., “Identification of Functional Domains in the Maize Transcriptional Activator C1: Comparison of Wild-Type and Dominant Inhibitor Proteins,” Genes Dev. 5(2):298-309 (1991).Applicant
• Gong, et al., “A Constitutively Expressed MYC-Like Gene Involved in Anthocyanin Biosynthesis From Perilla Frutescens: Molecular Characterization, Heterologous Expression in Transgenic Plants and Transactivation in Yeast Cells,” Plant Mol. Biol. 41(1):33-44 (1999).Applicant
• Gossen & Bujard, “Tight Control of Gene Expression in Mammalian Cells by Tetracycline-Responsive Promoters,” PNAS USA 89:5547 (1992).Applicant
• Greisman, et al., “A General Strategy for Selecting High-Affinity Zinc Finger Proteins for Diverse DNA Target Sites,” Science 275:657-661 (1997).Applicant
• Hagmann, et al., “The VP16 Paradox: Herpes Simplex Virus VP16 Contains a Long-Range Activation Domain But Within the Natural Multiprotein Complex Activates Only From Promoter-Proximal Positions,” J. Virol. 71:5952-5962 (1997).Applicant
• Halin, et al., “Decreased Pigment Epithelium-Derived Factor is Associated With Metastic Phenotype in Human and Rat Prostate Tumors,” Cancer Res 64:5664-5671 (2004).Applicant
• Han, et al., “Ligand-Directed Retroviral Targeting of Human Breast Cancer Cells,” PNAS USA 92:9747-9751 (1995).Applicant
• Hanahan, et al., “Fourteenth Annual Pezcoller Symposium : The Novel Dichotomy of Immune Interactions With Tumors,” Cancer Res 63:3005-3008 (2003).Applicant
• Hansen, et al., “Adeno-Associated Virus Encoding Green Flourescent Protein As a Label for Retinal Pigment Epithelium,” Invest Opthalmol Vis Sci 44:772-780 (2003).Applicant
• Heid, et al., “Real Time Quantitative PCR,” Genome Research 6:986-994 (1996).Applicant
• Hendrich. et al., “Genomic Structure and Chromosomal Mapping of the Murine and Human MBD1, MBD2, MBD3, and MBD4 Genes,” Mamm Genome 10:906-912 (1999).Applicant
• Henikoff, et al., “Amino Acid Substitution Matrices From Protein Blocks,” PNAS USA 89:10915 (1989).Applicant
• Hermonat, et al., “Use of Adeno-Associated Virus As a Mammalian DNA Cloning Vector: Transduction of Neomycin Resistance Into Mammalian Tissue Culture Cells,” PNAS 81:6466-6470 (1984).Applicant
• Hobo, et al., “A BZIP Factor, Trabi, Interacts With VP1 and Mediates Abscisic Acid-Induced Transcription,” PNAS USA 96:15,348-15,353 (1999).Applicant
• Holland, et al., “Detection of Specific Polymerase Chain Reaction Product by Utilizing the 5′→,3′ Exonuclease Activity of Thermus Aquaticus DNA Polymerase,” PNAS USA 88:7276-7280 (1991).Applicant
• Hope, et al., “Production of Large Unilamellar Vesicles by a Rapid Extrusion Procedure. Characterization of Size Distribution, Trapped Volume and Ability to Maintain a Memgrane Potential,” Biochim. Biophys. Acta 812:55-65 (1985).Applicant
• Hope, et al., “Generation of Multilamellar and Unilamellar Phospholipid Vesicles,” Chem. Phys. Lip. 40:89-107 (1986).Applicant
• Inaba, et al., “Generation of Large Numbers of Dendritic Cells From Mouse Bone Marrow Cultures Supplemented With Granulocyte/Macrophage Colony-Stimulating Factor,” J Exp Med 176:1693-1702 (1992).Applicant
• Jamieson, et al., “In Vitro Selection of Zinc Fingers With Altered DNA-Binding Specificity,” Biochemistry 33:5689-5695 (1994).Applicant
• Jamieson, et al., “A Zinc Finger Directory for High-Affinity DNA Recognition,” PNAS USA 93:12834-12839 (1996).Applicant
• Johann, et al., “GLVR1, A Receptor for Gibbon APE Leukemia Virus, is Homologous to a Phosphate Permease of Neurospora Crassa and Is Expressed at High Levels in the Brain and Thymus,” J Virol 66:1635-1640 (1992).Applicant
• Joukov, et al., “A Novel Vascular Endothelial Growth Factor, VEGF-C, is a Ligand for the F1t4 (VEGFR-3) and KDR (VEGFR-2) Receptor Tyrosine Kinases,” EMBO J. 15:290-298 (1996).Applicant
• Karlin, et al., “Applications and Statistics for Multiple High-Scoring Segments in Modular Sequences,” PNAS 90:5873-5887 (1993).Applicant
• Kearns, et al., “Recombinant Adeno-Associated Virus (AAV-CFTR) Vectors Do Not Integrate in a Site-Specific Fashion in an Immortalized Epithelial Cell Line,” Gene Ther. 9:748-755 (1996).Applicant
• Keck, et al., “Vascular Permeability Factor, An Endothelial Cell Mitogen Related to PDGF,” Science 246:1309-1312 (1989).Applicant
• Kim, et al., “Hybrid Restriction Enzymes: Zinc Finger Fusions FOK 1 Cleavage Domain,” PNAS 93:1156-1160 (1996).Applicant
• Kim, et al., “Getting a Handhold on DNA: Design of Poly-Zinc Finger Proteins With Femtomolar Dissociation Constants,” PNAS USA 95:2812-2817 (1998).Applicant
• Klimpel, et al., “Anthrax Toxin Protective Antigen is Activated by a Cell Surface Protease With the Sequence Specificity and Catalytic Properties of Furin,” PNAS USA 89:10277-10281 (1992).Applicant
• Knoepfler, et al., “Sin Meets Nurd and Other Tails of Repression,” Cell 99:447-450 (1999).Applicant
• Kohn, et al., “Engraftment of Gene-Modified Umbilical Cord Blood Cells in Neonates With Adenosine Deaminase Deficiency,” Nat Med 1:1017-1102 (1995).Applicant
• Kotin, “Prospects for the Use of Adeno-Associated Virus as a Vector for Human Gene Therapy,” Hum. Gene Ther. 5:793-801 (1994).Applicant
• Lee, et al., “Vascular Endothelial Growth Factor-Related Protein: A Ligand and Specific Activator of the Tyrosine Kinase Receptor F1t4,” PNAS USA 93:1988-1992 (1996).Applicant
• Lemon, et al., “Nuclear Receptor Cofactors as Chromatin Remodelers,” Curr. Opin. Genet. Dev. 9:499-504 (1999).Applicant
• Leo, et al., “The SRC Family of Nuclear Receptor Coactivators,” Gene 245:1-11 (2000).Applicant
• Leonnetti, et al., “Antibody-Targeted Liposomes Containing Oligodeoxyribonucleotides Complementary to Viral RNA Selectively Inhibit Viral Replication,” PNAS 87:2448-2451 (1990).Applicant
• Leung, et al., “Vascular Endothelial Growth Factor is a Secreted Angiogenic Mitogen,” Science 246:1306-1309 (1989).Applicant
• Lin, et al., “Inhibition of Nuclear Translocation of Transcription Factor NF-Kappa B by a Synthetic Peptide Containing a Cell Membrane-Permeable Motif and Nuclear Localization Sequence,” J. Biol. Chem. 270:14255-14258 (1995).Applicant
• Liu, et al., “Suppression of Growth and Transformation and Induction of Apoptosis by EGR-1,” Cancer Gene Ther. 5:3-28 (1998).Applicant
• Liu et al., “Design of Polydactyl Zinc-Finger Proteins for Unique Addressing Within Complex Genomes,” PNAS 94: 5525-5530 (1997).Applicant
• Lu et al., “Evaluation of Tumor-Specific Promoter Activities in Melanoma,” Gene Therapy 12:330-338 (2005).Applicant
• Malech, et al., “Prolonged Production of Nadph Oxidase-Corrected Granulocytes After Gene Therapy of Chronic Granulomatous Disease,” PNAS 94(22):12133-12138 (1997).Applicant
• Malik, et al., “Transcriptional Regulation Through Mediator-Like Coactivators in Yeast and Metazoan Cells,” Trends Biochem. Sci. 25:277-283 (2000).Applicant
• Manteuffel-Cymborowska, “Nuclear Receptors, Their Coactivators and Modulation of Transcription,” Acta Biochim. Pol. 46:77-89 (1999).Applicant
• Mapp, et al., “Activation of Gene Expression by Small Molecule Transcriptopn Factors,” PNAS USA 97:3930-3935 (2000).Applicant
• Margolin, et al., “Kruppel-Associated Boxes are Potent Transcriptional Repression Domains,” PNAS USA 91:4509-4513 (1994).Applicant
• Martin, et al., “Gene Delivery to the Eye Using Adeno-Associated Viral Vectors,” Methods 28:267-275 (2002).Applicant
• Matsumoto, et al., “Antiangiogenic Property of Pigment Epithelium-Derived Factor in Hepatocellular Carcinoma,” Hepatology 40:252-259 (2004).Applicant
• Mayer, et al., “Vesicles of Variable Sizes Produced by a Rapid Extrusion Procedure,” Biochim. Biophys. Acta 858:161-168 (1986).Applicant
• McKenna, et al., “Nuclear Receptor Coactivators: Multiple Enzymes, Multiple Complexes, Multiple Functions,” J. Steroid Biochem. Mol. Biol. 69:3-12 (1999).Applicant
• Miller, et al., “Construction and Properties of Retrovirus Packaging Cells Based on Gibbon Ape Leukemia Virus,” J. Virol. 65:2220-2224 (1991).Applicant
• Mistili & Spector, “Applications of the Green Flourescent Protein in Cell Biology and Biotechnology,” Nature Biotechnology 15:961-964 (1997).Applicant
• Mori, et al., “AAV-Mediated Gene Transfer of Pigment Epithelium-Derived Factor Inhibits Choroidal Neovascularization,” Invest Opthalmol Vis Sci 43:1994-2000 (2002).Applicant
• Morrison, “Transformation in Escherichia coli: Cryogenic Preservation of Competent Cells,” J. Bact. 132:349-351 (1977).Applicant
• Muzyczka, “Adeno-Associated Virus (AAV) Vectors: Will They Work?,” J Clin Invest 94:1351 (1994).Applicant
• Needham-Van Devanter, et al., “Characterization of an Adduct Between CC-1065 and a Defined Oligonucleotide Duplex,” Nucleic Acids Research 12:6159-6168 (1984).Applicant
• Needleman, et al., “A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins,” J. Mol. Biol. 48:443-453 (1970).Applicant
• Neering, et al., “Transduction of Primitive Human Hematopoietic Cells With Recombinant Adenovirus Vectors,” Blood 88:1147-1155 (1996).Applicant
• Novak, et al., “Functional Characterization of Protease-Treated Bacillus anthracis Protective Antigen,” J. Biol. Chem. 267:17186-17193 (1992).Applicant
• Ogawa, et al., “Rice Gibberellin-Insensitive Gene Homolog, Osgai, Encodes a Nuclear-Localized Protein Capable of Gene Activation At Transcriptional Level,” Gene 245:21-29 (2000).Applicant
• Ohno-Matsui et al., “Vascular Endothelial Growth Factor Upregulates Pigment Epithelium-Derived Factor Expression Via VEGFR-1 in Human Retinal Pigment Epithelial Cells,” Biochemical and Biophysical Res Comm 303:962-967 (2003).Applicant
• Okanami, et al., “HALF-1, A BZIP-Type Protein, Interacting With the Wheat Transcription Factor HBP-1A Contains a Novel Transcriptional Activation Domain,” Genes Cells 1:87-99 (1996).Applicant
• Oligino, et al., “Drug Inducible Transgene Expression in Brain Using a Herpes Simplex Virus Vector,” Gene Ther. 5:491-496 (1998).Applicant
• Pain, et al., “The Carbonic anhydrase II Gene, A Gene Regulated by Thyroid Hormone and Erythropoietin, is Repressed by the V-ERBA Oncogene in Erythrocytic Cells,” New Biol. 2:284-294 (1990).Applicant
• Palva, et al., “Secretion of Interferon by Bacillus subtilis,” Gene 22:229-235 (1983).Applicant
• Passoth, et al., “Analysis of the Hypdxia-Induced ADH2 Promoter of the Respiratory Yeast Pichia stipitis Reveals a New Mechanism for Sensing of Oxygen Limitation in Yeast,” Yeast 20:39-51 (2003).Applicant
• Pearson, et al., “Improved Tools for Biological Sequence Comparison,” PNAS USA 85:2444-2448 (1988).Applicant
• Pengue, et al., “Repression of Transcriptional Activity at a Distance by the Evolutionarily Conserved Krab Domain Present in a Subfamily of Zinc Finger Proteins,” Nucl. Acids Res. 22:2908-2914 (1994).Applicant
• Perelle, et al., “Characterization of Clostridium Perfringens IOTA-Toxin Genes and Expression in Escherichia coli,” Infect. Immun. 61:5147-5156 (1993).Applicant
• Pina, et al., “Nucleosome Positioning Modulates Accessibility of Regulatory Proteins to the Mouse Mammary Tumor Virus Promoter,” Cell 60:719-731 (1990).Applicant
• Pomerantz, et al., “Analysis of Homeodomain Function by Structure-Based Design of a Transcription Factor,” PNAS 92: 9752-9756 (1995).Applicant
• Pomerantz, et al., “Structure-Based Design of Transcription Factors,” Science 267:93-96 (1995).Applicant
• Prochiantz, “Getting Hydrophilic Compounds Into Cells: Lessons From Homeopeptides,” Current Opinion in Neurobiology 6:629-634 (1996).Applicant
• Rebar, et al, “Zinc Finger Phage: Affinity Selection of Fingers With New DNA-Binding Specifities,” Science 263:671-673 (1994).Applicant
• Remy, et al., “Gene Transfer With a Series of Lipophilic DNA-Binding Molecules,” Bioconjugate Chem 5:647-654 (1994).Applicant
• Rendahl, et al., “Regulation of Gene Expression in Vivo Following Transduction by Two Separate RAAV Vectors,” Nat. Biotechnol 16:757-761 (1998).Applicant
• Renneisen, et al., “Inhibition of Expression of Human Immunodeficiency Virus-1 in Vitro by Antibody-Targeted Liposomes Containing Antisense RNA to the ENV Region,” J. Biol. Chem. 265:16337-16342 (1990).Applicant
• Rhodes, et al., “Zinc Fingers: They Play a Key Part in Regulating the Activity of Genes in Many Species, From Yeast to Humans, Fewer Than 10 Years Ago No One Knew They Existed,” Scientific American 268:56-65 (1993).Applicant
• Robertson, et al., “DNMT1 Forms a Complex With RB, E2F1 and HDAC1 and Represses Transcription From E2F-Responsive Promoters,” Nature Genet. 25:338-342 (2000).Applicant
• Robyr, et al., “Nuclear Hormone Receptor Coregulators in Action: Diversity for Shared Tasks,” Mol. Endocrinol 14:329-347 (2000).Applicant
• Rosenecker, et al., “Adenovirus Infection in Cystic Fibrosis Patients: Implications for the Use of Adenoviral Vectors for Gene Transfer,” Infection 24:5-8 (1996).Applicant
• Samulski, et al., “Helper-Free Stocks of Recombinant Adeno-Associated Viruses: Normal Integration Does Not Require Viral Gene Expression,” J. Virol. 63:3822-3828 (1989).Applicant
• Sap, et al., “Repression of Transcription Mediated at a Thyroid Hormone Response Element by the V-ERB-A Oncogene Product,” Nature 340:242-244 (1989).Applicant
• Sebo, et al., “Cell-Invasive Activity of Epitope-Tagged Adenylate Cyclase of Bordetella pertussis Allows in Vitro Presentation of a Foreign Epitope to CD8+ Cytotoxic T Cells,” Infect Immun 63:3851-3857 (1995).Applicant
• Seipel, et al., “Different Activation Domains Simulate Transcription From Remote (‘Enhancer’) and Proximal (‘Promoter’) Positions,” EMBO J. 11:4961-4968 (1996).Applicant
• Smith and Waterman, “Comparison of Biosequences,” Advances in Applied Mathematics 2:482-489 (1981).Applicant
• Sommerfelt, et al., “Receptor Interference Groups of 20 Retroviruses Plating on Human Cells,” Virol. 176:58-59 (1990).Applicant
• Sprenger-Haussels, et al., “Transactivation Properties of Parsley Proline-Rich Bzip Transcription Factors,” Plant J. 22:1-8 (2000).Applicant
• Steele, et al., “Pigment Epithelium-Derived Factor: Neurotrophic Activity and Identification As a Member of the Serine Protease Inhibitor Gene Family,” PNAS USA 90:1526-1530 (1992).Applicant
• Stellmach, et al., “Prevention of Ischemia-Induced Retinopathy by the Natural Ocular Antiangiogenic Agent Pigment Epithelium-Derived Factor,” PNAS USA 98:2593-2597 (2001).Applicant
• Stenmark, et al., “Peptides Fused to the Amino-Terminal End of Diphtheria Toxin are Translocated to the Cytosol,” J. Cell. Biol. 113:1025-1032 (1991).Applicant
• Sterman, et al., “Adenovirus-Mediated Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy in Patients With Localized Malignancy: Results of a Phase I Clinical Trial in Malignant Mesothelioma,” Hum. Gene Ther. 7:1083-1089 (1998).Applicant
• Studeny, et al., “Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents,” J. Natl Cancer Inst 96:1593-1603 (2004).Applicant
• Szoka, et al., “Comparative Properties and Methods of Preparation of Lipid Vesicles (Liposomes),” Ann Rev. Biophys. Bioeng. 9:467-508 (1980).Applicant
• Tai, et el., “Concurrent Delivery of GM-CSF and Endostatin Genes by a Single Adenoviral Vector Provides a Synergistic Effect on the Treatment of Orthotopic Liver Tumors,” J. Gene Medicine 5:386-398 (2003).Applicant
• Thiesen, “Multiple Genes Encoding Zinc Finger Domains are Expressed in Human T Cells,” New Biologist 2:363-374 (1990).Applicant
• Tombran-Tink, et al., “Therapeutic Prospects for PEDF: More Than a Promising Angiogenesis Inhibitor,” Trends Mol Med 9:224-250 (2003).Applicant
• Topf, et al., “Regional ‘Pro-Drug’ Gene Therapy: Intravenous Administration of an Adenoviral Vector Expressing the E. coli Cytosine Deaminase Gene and Systemic Administration of 5-Fluorocytosine Suppresses Growth of Hepatic Metastasis of Colon Carcinoma,” Gene Ther 5:507-513 (1998).Applicant
• Torchia, et al., “Co-Activators and Co-Repressors in the Integration of Transcriptional Responses,” Curr. Opin. Cell. Biol. 10:373-383 (1998).Applicant
• Tratschin, et al., “Adeno-Associated Virus Vector for High-Frequency Integration, Expression, and Rescue of Genes in Mammalian Cells,” Mol. Cell. Biol. 5:3251-3260 (1985).Applicant
• Tratschin, et al., “A Human Parvovirus, Adeno-Associated Virus, as a Eucaryotic Vector: Transient Expression and Encapsidation of the Procaryotic Gene for Chloramphenicol Acetyltransferase,” Mol. Cell Biol. 4:2072-2081 (1984).Applicant
• Tyler, et al., “The “Dark Side” of Chromatin Remodeling: Repressive Effects on Transcription,” Cell 99:443-446 (1999).Applicant
• Ulmasov, et al., “Activation and Repression of Transcription by Auxin-Response Factors” PNAS USA 96:5844-5849 (1999).Applicant
• Utley, et al., “Transcriptional Activators Direct Histone Acetyltransferase Complexes to Nucleosomes,” Nature 394:498-502 (1998).Applicant
• Wagner, et al., “Efficient and Persistent Gene Transfer of AAV-CFTR in Maxillary sinus,” Lancet 351:1702-1703 (1998).Applicant
• Wallace, et al., “A Set of Synthetic Oligodeoxyribonucleotide Primers for DNA Sequencing in the Plasmid Vector pBR322,” Gene 16:21-26 (1981).Applicant
• Wang, et al., “Positive and Negative Regulation of Gene Expression in Eukaryotic Cells With an Inducible Transcriptional Regulator,” Gene Ther. 4:432-441 (1997).Applicant
• Wang, et al., “PH-Sensitive Immunoliposomes Mediate Target-Cell-Specific Delivery and Controlled Expression of a Foreign Gene in Mouse,” PNAS USA 84:7851-7855 (1987).Applicant
• Wang, et al., “Supression of Angiogenesis and Tumor Growth by Adenoviral-Mediated Gene Transfer of Pigment Epithelium-Derived Factor,” Molecular Therapy 8:72-79 (2003).Applicant
• Welsh, et al., “Adenovirus-Mediated Gene Transfer for Cystic Fibrosis: Part A. Safety of Dose and Repeat Administration in the Nasal Epithelium. Part B. Clinical Efficacy in the Maxillary Sinus,” Hum. Gene Ther. 2:205-218 (1995).Applicant
• West, et al., “Gene Expression in Adeno-Associated Virus Vectors: The Effects of Chimeric MRNA Structure, Helper Virus, and Adenovirus VA1 RNA,” Virology 160:38-47 (1987).Applicant
• Williams, et al., “Low Density Lipoprotein Receptor-Independent Hepatic Uptake of a Synthetic, Cholesterol-Scavenging Lipoprotein: Implications for the Treatment of Receptor-Deficient Atherosclerosis,” PNAS 85:242-246 (1988).Applicant
• Wilson, et al., “Formation of Infectious Hybrid Virions With Gibbon APE Leukemia Virus and Human T-Cell Leukemia Virus Retroviral Envelope Glycoproteins and the GAG and POL Proteins of Moloney Murine Leukemia Virus,” J Virol 63:2374-2378 (1989).Applicant
• Witzgall, et al., “The Kruppel-Associated Box-A (KRAB-A) Domain of Zinc Finger Proteins Mediates Transcriptional Repression,” PNAS USA 91:4514-4518 (1994).Applicant
• Wu, et al., “Building Zinc Fingers by Selection: Toward a Therapeutic Application,” PNAS 92:344-348 (1995).Applicant
• Wu, et al., “Functional Analysis of HD2 Histone Deacetylase Homologues in Arabidopsis thaliana,” Plant J. 22:19-27 (2000).Applicant
• Zenke, et al., “V-ERBA Specifically Suppresses Transcription of the Avian Erythrocyte Anion Transporter (Band 3) Gene,” Cell 52:107-119 (1988).Applicant
• Zenke, et al., “V-ERBA Oncogene Activation Entails the Loss of Hormone-Dependent Regulator Activity of C-ERBA,” Cell 61:1035-1049 (1990).Applicant
• Zhang, et al., “Synthetic Zinc Finger Transcription Factor Action at An Endogenous Chromosomal Site. Activation of the Human Erythropoietin Gene,” Journal of Biological Chemistry 275(43): 33850-33860 (2000).Applicant
• Reik, et al., “An Oncolytic Adenovirus Armed With a GM-CSF Activating Designed Zinc-Finger Protein Transcription Factor: A Potential Cancer Vaccine Approach,” Molecular Therapy vol. 9, Supplement 1, p. S238 (2004).Applicant
• Ohno-Matsui, et al., “Novel Mechanism for Age-Related Macular Degeneration: An Equilibrium Shift Between the Angiogenesis Factors VEGF and PEDF,” Journal of Cellular Physiolgy 189:323-333 (2001).Applicant
• Wong, et al., “Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of the Natural and Recombinant Proteins,” Science 228:810-815 (1985).Applicant